表紙:動物腸内健康の世界市場-2022-2029
市場調査レポート
商品コード
1129257

動物腸内健康の世界市場-2022-2029

Global Animal Intestinal Health Market - 2022-2029

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
動物腸内健康の世界市場-2022-2029
出版日: 2022年09月29日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

動物腸内健康に対する意識の高まりが、市場成長の原動力になると予想されます。

動物用医薬品の世界企業であるオールテックは、家畜や家禽を飼育する農家向けに有機栄養補助食品を提供しています。腸の健康に重点を置くことで、同社は一貫して健康な動物を生産し、予防的および準抗生物質の使用を減らすための「オールテック抗生物質削減プログラム」を確立しています。このプログラムは、酪農家がアクションプランを作成するのに役立ちます。このプログラムは、自分の牛群や羊群の健康状態を改善するために行動を起こそうとする家畜の飼い主のためのものです。専門家集団が生産者に助言し、指導を行います。Alltech Gut Health Platformの業界アドバイザー、獣医師、栄養士は、カスタマイズされたアクションプランを作成し、サポートを提供することで、農場の抗生物質使用量を減らすために生産者をサポートします。例えば、英国の養豚場では、オールテックの抗生物質削減プログラムが全面的に実施されました。したがって、農家や動物生産者の意識の高まりは、動物腸内健康のためのサプリメントの需要を増加させています。したがって、上記の記述から、予測期間中に市場が牽引されることが予想されます。

抑制要因

腸の健康のために利用される飼料添加物に関連する価格の上昇、非抗生物質成長促進剤の開発に使用される有効成分の費用の上昇、およびさまざまな飼料添加物に関する厳しい規制は、予測期間中に市場が阻害されると予想されるいくつかの要因です。

産業分析

動物腸内健康市場は、サプライチェーン分析、価格分析など、様々な産業要因に基づいた市場の詳細な分析を提供します。

COVID-19の影響分析

COVID-19のパンデミックは、市場に中程度の影響を及ぼしています。COVID-19流行時の輸送制限やその他の社会的排除要因によって、動物の供給と生産性が劇的に低下しました。COVIDの最初のインパクトはパニック買いを引き起こし、肉や乳製品の売上を増加させました。したがって、パンデミックは牛製品のサプライチェーンとプロセスを中断させる。多くの企業は、製品の供給を維持し、サプライチェーンを保護するために、他の地域へと変化していきます。したがって、上記の文から、市場は影響を受け、それは経済活動の再開と迅速にトラクションを得ることが期待されるようになっています。

世界の動物腸内健康市場レポートでは、約45+市場データ表、40+図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場インパクトファクター
    • 促進要因
      • 動物腸内健康に対する意識の高まりが市場成長の原動力になると予想されます。
    • 抑制要因
      • 腸の健康のために利用される飼料添加物の価格上昇は、市場成長の妨げになると予想されます。
    • 機会
    • 影響分析

第5章 産業分析

  • サプライチェーン分析
  • 価格設定分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 飼育動物別

  • 水産養殖
  • 家禽類
  • 反芻動物
  • その他

第8章 供給源別

  • 微生物由来
  • 植物由来

第9章 形態別

  • 乾燥
  • 液体
  • その他

第10章 添加物別

  • プロバイオティクス
  • プレバイオティクス
  • 免疫賦活剤
  • フィトジェニック
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第13章 企業プロファイル

  • AB Vista
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Nutrition & Biosciences
  • Kemin Industries, Inc.
  • Lesaffre
  • Adisseo
  • Cargill, Incorporated
  • Evonik Industries
  • Novozymes
  • Pure Cultures
  • Chr. Hansen Holdings

第14章 動物腸内健康の世界市場-DataM

目次
Product Code: DMVH5845

Market Overview

Animal Intestinal Health Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Animal intestinal health defines gut health as physiological and functional elements, such as nutrition digestion and absorption, host metabolism and energy production, a stable and functional microbiota/microbiome, defensive systems, and the interactions between these elements. Good health is a prerequisite for any animal to fulfill its genetic potential. The connections to daily increases, regularity, and feed conversion are obvious. Diet has a bearing on health, especially regarding reducing risks and curing disorders. Animal husbandry can impact one's health almost any way, and animal nutrition is no exception.

Market Dynamics

Rising awareness regarding animals' intestinal health is expected to drive market growth.

Global animal health company Alltech offers organic dietary supplements to farmers raising livestock and poultry. By putting a strong emphasis on gut health, the company has established an Alltech Antibiotic Reduction program to produce consistently healthy animals and decrease prophylactic and metaphylactic antibiotic use. The program can help the farmer create an action plan. This program is for livestock owners who are dedicated to taking action to improve the health of their herd or flock. A group of professionals advises and mentor the producer. The Alltech Gut Health Platform's industry advisors, veterinarians, and nutritionists support producers in reducing farm antibiotic use by developing a customized action plan and offering support. For instance, The full Alltech Antibiotic Reduction program was implemented on a pig farm in the United Kingdom. Therefore, increasing awareness among farmers and animal producers has increased the demand for animal intestinal health supplements. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

Increasing prices associated with feed additives utilized for intestinal health, rising expense of active ingredients used in the development of non-antibiotic growth promoters, and stringent regulations regarding different feed additives are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The animal intestinal health market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. Due to transportation limitations and other social exclusionary factors during the COVID-19 epidemic, animal supplies and productivity drastically decreased. The first impact of COVID led to panic buying, which increased sales of meat and dairy products. Therefore, the pandemic interrupts the supply chain and process for cattle products. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Probiotics segment is expected to hold the largest market share in animal intestinal health market

The probiotics segment is expected to dominate in 2021. Probiotics make up a sizable portion of the feed supplements utilized in the cattle business. When properly ingested, probiotics, which are microbial feed supplements, help the host's health. Fish and animals may develop healthier and more rapidly with the help of probiotics. It also aids in speeding up an animal's digestion. It is being utilized more frequently to improve cattle performance as a safe and effective substitute for antibiotics. Animal growth, immunological response, nutrient digestibility and absorption, gut microbiota composition, and meat quality were all improved by probiotics.

Moreover, more significant research describing particular strains, determining the ideal dosage, and comprehending the network of interactions between probiotics and the gut microbiota may aid in creating probiotic mixes for animal feed and meat products that are more successful. Farm animals treated with probiotics had lower morbidity and vitality, improved eating habits, and produced more. Additionally, their application has expanded in the food business due to probiotics' capacity to suppress a wide variety of harmful bacteria. Probiotic supplements also contributed to the increase in broiler chicken body weight. Therefore, it has increased the demand for probiotics. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global animal intestinal health market

In 2021, North America accounted for the highest revenue share. Increasing consumption of meat and dairy products, growing livestock count and the associated animal feed required for the healthy maintenance of the livestock and product launches by the region's key market players are some factors the market is expected to boost in the forecast period. For instance, According to the United States Department of Agriculture Economic Research Service, the country produced more than 2,26,258 million pounds of milk in 2021. Moreover, to feed the gastrointestinal tract in calves, optimize average daily gains, support calf immune system development, and reinforce a healthy gut microbiome without using antibiotics at any stage of production, Alltech released Bio-Mos 2 as a second-generation feed additive in April 2022. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the animal intestinal health market are AB Vista, Nutrition & Biosciences, Kemin Industries, Inc., Lesaffre, Adisseo, Cargill, Incorporated, Evonik Industries, Novozymes, Pure Cultures, Chr. Hansen Holdings.

Kemin Industries, Inc.:

Overview:

Kemin was established in 1961 and headquartered in Des Moines, Iowa. It offers molecules that have been specially created to assist both human and animal health and nutrition. The company is dedicated to the safety of food and feed. It maintains production facilities where specialized ingredients are created for the food and feed industries and the health, nutrition, and beauty sectors. Moreover, the business involves pharma, food technologies, nutrisurance, and personal care.

Product Portfolio:

COZANTE: A patented polyphenol from plants called COZANTE is used to help chicken farms reduce Eimeria species. Its active component is delivered using Kemin's unique spray freezing technology (SFT) of encapsulation. This procedure will deliver the active substance evenly along the gut length.

The global animal intestinal health market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising awareness regarding animals' intestinal health is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Increasing prices associated with feed additives utilized for intestinal health is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Live Stock

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 7.1.2. Market Attractiveness Index, By Live Stock Segment
  • 7.2. Aquaculture*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Poultry
  • 7.4. Ruminant
  • 7.5. Swine
  • 7.6. Others

8. By Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2. Market Attractiveness Index, By Source Segment
  • 8.2. Microbial*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Plant Based

9. By Form

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 9.1.2. Market Attractiveness Index, By Form Segment
  • 9.2. Dry*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Liquid
  • 9.4. Others

10. By Additive

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 10.1.2. Market Attractiveness Index, By Additive Segment
  • 10.2. Probiotics*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Prebiotics
  • 10.4. Immunostimulants
  • 10.5. Phytogenics
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. AB Vista*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Nutrition & Biosciences
  • 13.3. Kemin Industries, Inc.
  • 13.4. Lesaffre
  • 13.5. Adisseo
  • 13.6. Cargill, Incorporated
  • 13.7. Evonik Industries
  • 13.8. Novozymes
  • 13.9. Pure Cultures
  • 13.10. Chr. Hansen Holdings

LIST NOT EXHAUSTIVE

14. Global Animal Intestinal Health Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us